Delivery Order SPE2DR25D7058-SPE2DR26F8DPF
Award Date 12/22/25
Potential Completion Date 1/14/26
Potential Value $25K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $25,332.96 delivery order to AmerisourceBergen Drug Corp on December 22, 2025, for the supply of Ocrevus 300 mg/10 mL vials. This is a firm fixed price contract with an ultimate completion date of January 14, 2026, with performance to be executed at the awardee's facility in Conshohocken, Pennsylvania. The award represents a competitively awarded, non-set-aside delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a $63,332.40 delivery order to AmerisourceBergen Drug Corp for 300 mg/10 mL vials of Ocrevus, a prescription pharmaceutical product. This firm fixed-price contract, awarded December 15, 2025, with an ultimate completion date of January 7, 2026, carries no set-aside designation and represents a competitively awarded procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a $48,077.16 firm fixed price delivery order to AmerisourceBergen Drug Corp for 10 milliliter vials of Ocrevus 300 mg on September 10, 2025, with an ultimate completion date of October 1, 2025. This contract was not set-aside and represents a competitive award to the pharmaceutical distributor. Performance will occur at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. As a child delivery order, this award falls under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Ocrevus 300 mg/10 mL vials with a ceiling value of $34,713.66. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The contract is scheduled for ultimate completion by December 30, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Ocrevus...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Ocrevus 300 mg/10 mL vials totaling $25,332.96 with completion targeted for December 31, 2025. This competitively awarded, non-set-aside contract represents a firm fixed-price delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December...
- The Defense Logistics Agency awarded a $64,447.63 delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Ocrevus 300 mg/10 mL vials. This is a firm fixed price contract with a completion date of December 22, 2025, and represents a non-competitive delivery order issued under an existing contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $24,038.58 to AmerisourceBergen Drug Corp for the supply of Ocrevus 300 mg/10 mL vials on August 18, 2025. The contract is firm fixed price with no set-aside designation and is scheduled for completion by September 9, 2025. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $24,038.58 to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Ocrevus 300 mg/10 mL vials. This is a firm fixed price delivery order with an ultimate completion date of June 24, 2025, and represents a non-competitive, non-set-aside award. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Ocrevus 300 mg/10 mL vials valued at $32,694.46 under a firm fixed-price contract. The delivery order is non-set-aside and competitively awarded, with a completion date of June 24, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ocrevus 300 mg/10 mL vials on December 17, 2025, with a contract ceiling value of $25,332.96 and an ultimate completion date of January 9, 2026. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award constitutes a child contract under...